Doximity, Inc.

Listed Company

DOCSCIK 0001516513NYSELarge AcceleratedServices-Computer Programming ServicesDelawareFY ends Mar 31

Period

FY 2026

Revenue

$644.86M

Net Income

$196.05M

Total Assets

$1.12B

Equity

$950.84M

Shares Out

183.06M

Op. Cash Flow

$326.46M

Business

Doximity, Inc. operates a digital professional platform serving U.S. medical professionals, providing a network-centric environment that connects physicians and other clinicians. It offers member-facing tools including verified professional profiles, a personalized AI-curated newsfeed, clinical workflow tools (telehealth, secure messaging, fax, eSignature) and AI-powered writing assistants. Commercial offerings are organized into Marketing, Hiring, and Workflow Solutions for pharmaceutical manufacturers, health systems, and recruiters. The platform primarily serves U.S.-based clinicians and customers via a free member web and mobile app plus enterprise subscription sales and integrations with health system IT.

Summary from filing dated 2025-05-20

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31	Mar 31, 2024 2024-03-31
Revenue	645	570	475
Cost of revenue	70	56	51
Gross profit	575	515	425
Operating expenses:	—	—	—
Research and development	131	93	82
Sales and marketing	164	146	133
General and administrative	65	46	38
Restructuring and impairment charges	0	2	8
Total operating expenses	360	287	261
Income from operations	215	228	164
Other income, net	35	36	21
Income before income taxes	250	264	185
Provision for income taxes	54	40	38
Net income	196	223	148
Net income per share attributable to Class A and Class B common stockholders:	—	—	—
Basic (in dollars per share)	1.05	1.19	0.78
Diluted (in dollars per share)	0.98	1.11	0.72
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:	—	—	—
Basic (in shares)	187	187	190
Diluted (in shares)	199	201	206

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31
Assets	—	—
Current assets:	—	—
Cash and cash equivalents	219	210
Marketable securities	529	706
Accounts receivable, net of allowance for doubtful accounts of $1,345 and $1,937 as of March 31, 2026 and 2025, respectively	145	128
Prepaid expenses and other current assets	51	45
Total current assets	944	1,089
Property and equipment, net	18	14
Deferred income tax assets	32	60
Operating lease right-of-use assets	7	9
Intangible assets, net	35	23
Goodwill	85	68
Other assets	2	2
Total assets	1,124	1,264
Liabilities and Stockholders’ Equity	—	—
Current liabilities:	—	—
Accounts payable	4	1
Accrued expenses and other current liabilities	43	38
Deferred revenue, current	106	114
Operating lease liabilities, current	2	2
Total current liabilities	155	156
Deferred revenue, non-current	400,000	280,000
Operating lease liabilities, non-current	8	10
Contingent earn-out consideration liability, non-current	0	6
Other liabilities, non-current	9	9
Total liabilities	173	182
Commitments and contingencies (Note 14)	—	—
Stockholders’ Equity	—	—
Preferred stock, $0.001 par value; 100,000 shares authorized as of March 31, 2026 and 2025, respectively; zero shares issued and outstanding as of March 31, 2026 and 2025, respectively	0	0
Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of March 31, 2026 and 2025, respectively; 183,060 and 188,875 shares issued and outstanding as of March 31, 2026 and 2025, respectively	183,000	189,000
Additional paid-in capital	1,002	894
Accumulated other comprehensive income	28,000	1
Retained earnings (accumulated deficit)	−51	187
Total stockholders' equity	951	1,083
Total liabilities and stockholders’ equity	1,124	1,264

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31	Mar 31, 2024 2024-03-31
Cash flows from operating activities	—	—	—
Net income	196	223	148
Adjustments to reconcile net income to net cash provided by operating activities:	—	—	—
Depreciation and amortization	14	11	10
Deferred income taxes	32	−12	−9
Stock-based compensation, net of amounts capitalized	122	72	51
Non-cash lease expense	2	2	2
Accretion of discount on marketable securities, net	8	12	5
Amortization of deferred contract costs	13	10	9
Impairment of long-lived assets	0	2	0
Other	−314,000	−270,000	−3
Changes in operating assets and liabilities, net of effect of acquisition:	—	—	—
Accounts receivable	17	27	−4
Prepaid expenses and other assets	8	−3	20
Deferred contract costs	14	12	9
Accounts payable, accrued expenses and other liabilities	4	−663,000	8
Deferred revenue	−8	15	−6
Operating lease liabilities	−2	−2	−2
Net cash provided by operating activities	326	273	184
Cash flows from investing activities	—	—	—
Cash paid for acquisition, net of cash acquired	27	0	0
Purchases of property and equipment	0	0	147,000
Purchases of intangible assets	62,000	0	0
Internal-use software development costs	9	7	6
Purchases of marketable securities	389	676	473
Maturities of marketable securities	561	635	435
Sales of marketable securities	10	17	75
Net cash provided by (used in) investing activities	147	−29	31
Cash flows from financing activities	—	—	—
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants	10	20	13
Proceeds from issuance of common stock in connection with the employee stock purchase plan	4	4	3
Taxes paid related to net share settlement of equity awards	41	27	7
Repurchase of common stock	432	120	281
Payment of contingent consideration related to a business combination	5	5	5
Payment of excise taxes on share repurchases	0	1	0
Net cash used in financing activities	−464	−131	−277
Net increase (decrease) in cash and cash equivalents	10	113	−61
Cash and cash equivalents, end of period	—	—	—
Cash and cash equivalents, end of period	—	—	—
Supplemental disclosures of cash flow information	—	—	—
Cash paid for taxes, net of refunds	22	56	51
Non-cash financing and investing activities	—	—	—
Equity awards included in purchase consideration	10	0	0
Capitalized stock-based compensation for internal-use software development costs	4	2	1
Excise tax payable on share repurchases	2	0	1

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro